Several analysts at Wall Street have already given the stocks of PGEN a rating of buy. Around six of the analysts covering the firm were the first ones to report this. According to a report, one of the analysts covering prescribed a rating of sell, while five others issued a rating of buy. Currently, the price target of PGEN based on one year has been set at $12.
The Stock Commentary On PGEN
There have been quite a few research equities that have commented on the stocks of PGEN. Stifel Nicolaus has already put up a rating of buy on the firm with a price target of $13. Wells Fargo & Company have followed suit with a $14 price target and a rating of overweight. B. Riley has also prescribed the stocks of PGEN with a rating of buy, and a price objective of $10. In the end, HC Wainwright also went down the same road, with a price target set at $10, and a rating of buy- which was published in a 16th December research report.
The stocks of PGEN traded on Thursday at $8.57. The market cap of the firm has been set at $1.59 billion, with a 2.31 beta, and a -4.56 PE ratio. The company has a 4.59 quick ratio, with a 4.93 current ratio, and a 3.31 debt-to-equity ratio. The moving average price of the company over 50 days has been set at $8.49, with a moving average price of the company over 200 days set at $6.68. The year low for this firm was $1.26, with the year high set at $11.10.
